BACKGROUND Physical appearance influences nearly every aspect of human life-impacting how people are judged and subsequently treated by others.
P hysical appearance influences nearly every aspect of the lives, including interpersonal relationships, personal sense of well-being, employment opportunities, and financial compensation. [1] [2] [3] [4] [5] Americans spend more than $12 billion per year on cosmetic procedures to enhance their appearance. 6 The epidemic of skin cancer affects a growing number of Americans, and surgeries to treat their tumors can leave scars that change their physical appearance and negatively impact psychosocial functioning. This article reviews the literature documenting the influence of physical appearance and facial scarring on psychosocial functioning in patients with skin cancer and provides suggestions for the identification and management of patients at risk for psychosocial impairment from scarring.
Facial Scarring Affects Identity
Americans place a high value on maintaining and preserving a "normal" physical appearance. Although it is difficult to define a "normal" facial appearance, individuals within and across races consistently rate appearance more favorably when faces are symmetric 7 and have traits such as skin health and color that represent averages, rather than extremes, of a population. 8 People with facial disfigurement are often stigmatized for appearing different than "normal" 9 and may be considered "dysfunctional" by others. 10, 11 Strangers who observe photographs of people with facial abnormalities such as scars are more likely to judge them as dishonest, unsuitable for employment, unintelligent, and unattractive. 12 If a person has visible scarring, gaze patterns of observers deviate to the site of the scar. 13 Those with noticeable scars may grow self-conscious when they recognize the altered gaze patterns of onlookers, and the perceived stigma may interfere with communication skills, personal relationships, work life, and leisure activities. 14 To avoid disfigurement, the majority of adults would "go to any lengths to minimize scarring, even if they resulted in only small improvements in scar appearance." 15 In 1 study, half of adults were so averse to scars of the face that they would risk at least a 7% chance for death to obtain a normal physical appearance, and more than 13% of adults would accept a 30% to 45% risk for death to obtain a normal face. 10 The Psychosocial Impact of Scarring After Skin Cancer Surgery
The psychosocial impact of scarring from the treatment of facial skin cancers affects patients across all demographics. Whereas younger patients tend to experience the greatest preoperative anxiety levels, 16 elderly patients also express great concern for their physical appearance. 17 Men and women may express equal concern about the appearance of a scar. 15 Some patients fear the prospect of facial disfigurement from surgery for cancer of the face even more than the possibility of postoperative limitations in vision, breathing, or speech. [18] [19] [20] Furthermore, high levels of preoperative anxiety about possible disfigurement can diminish the ability to cope effectively after surgery. 21, 22 The satisfaction of patient with skin cancer correlates significantly with the final aesthetic outcome of surgery. 23 Postoperatively, many patients report dissatisfaction with their appearance, especially if multiple treatment modalities are used (e.g., surgery plus radiation). [24] [25] [26] Patients may be dissatisfied if their surgical scar is larger than expected. 27 As patients try to reconcile the memory of their appearance before surgery, their notion of ideal appearance, and the actual appearance after surgery, 16 many will struggle to adapt to the changes in their appearance. 28 Anxiety about appearance and social isolation after skin cancer surgery can result in a decreased quality of life (QOL), which can have economic implications for some patients. 17, [29] [30] [31] Among the 13% of cancer survivors who quit work for cancerrelated reasons, patients with head and neck cancer have the highest adjusted risk for going on medical disability because of the psychosocial burden of dysfunction and disfigurement. 32, 33 Medical professionals may underestimate and misinterpret the importance of physical appearance and scarring for patients. 34 Patients report that their scars can be dismissed as trivial by their clinician, 14 or they believe more concerned with their own facial scarring than their surgeon. 15 However, the degree of patient psychosocial distress is not associated with the objective severity or size of a scar but rather the perceptions of scar severity by the patient. Even if onlookers grade a scar to be acceptable by objective criteria, the patients' own subjective assessment of the scar visibility is the primary influence on patients' psychosocial morbidity. 37 What some clinicians may consider nominal scarring may translate into substantial anxiety and self-consciousness for patients. 38 This point is underscored by the observation that some patients with scars in nonvisible locations can experience worse psychological stress than patients with visible scars. 37 
Instruments to Measure Patient-Reported Outcomes for Skin Cancer Treatment May Help to Quantify Psychosocial Distress
Although numerous instruments have been validated to measure scar appearance, 39 objective assessment of scar appearance does not necessarily correlate with the degree of psychosocial distress. 35, 36 To assess the psychosocial impact of scarring after surgery for skin cancer, patient-reported outcome (PRO) instruments may prove most useful. Patient-reported outcome P H Y S I C A L A P P E A R A N C E A N D S K I N C A N C E R instruments that assess changes in QOL and other relevant psychosocial domains are increasingly recognized by the Agency for Healthcare Research and Quality, as well as other agencies such as the Food and Drug Administration and National Institutes of Health as important treatment outcomes. 40 Such QOL instruments have been used for patients with psoriasis, acne, and atopic dermatitis. [41] [42] [43] However, these general QOL instruments have less relevance for patients with skin cancer. 44 In particular, existing tools created for patients with melanoma are not generalizable to patients with other skin cancer, as their validation occurred in a population with advanced disease who often struggle with different preoperative and postoperative concerns. [44] [45] [46] Recent review articles have identified the most relevant PRO tools for use in patients with nonmetastatic facial skin cancer. [47] [48] [49] There are presently 5 validated tools available for research and clinical use ( Table 1) . Although these questionnaires are designed to obtain baseline information and identify changes that occur with treatment, they have limited capability to elicit concerns about physical appearance and scarring. Among these 5 tools, the Facial Skin Cancer Index (FSCI) is most helpful to investigate scar concerns, as it possesses an appearance subscale specific to scar visibility (Figure 1 ). 48 The Patient-Reported Impact of Scars Measure (PRISM) offers an alternative to these previously validated PRO instruments. 55 Although it was not developed and validated specifically in a skin cancer population, the PRISM provides an alternative measure to quantify the impact of scarring on patients. This 37-item tool is consisted of 13 questions related to scar symptoms (e.g., "my scar itches a lot") and 24 questions related to QOL (e.g., "my scar affects my confidence"). The PRISM allows for monitoring of patient progression through treatment and also can be used to compare subgroups of patients. Use of the PRISM in conjunction with measures of scar severity such as the Vancouver Scar Scale can provide a comprehensive global scar severity assessment. Although the PRISM has not been used with skin cancer patients, future studies will be helpful to assess its utility. 56 
Attention to Psychosocial Concerns May Improve Outcomes for Patients With Skin Cancer
Addressing the psychosocial concerns about scarring may improve outcomes after treatment of skin cancer. High levels of preoperative anxiety about possible disfigurement can diminish the ability to cope effectively after surgery. 21, 22 Conversely, patients with better preoperative coping ability predict a better postoperative behavioral response. 16 Patients with better pretreatment skin-related QOL, less comorbidity, and better mental health status are more likely to have better skin-related QOL and long-term satisfaction after nonmelanoma skin cancer (NMSC) treatment. 57, 58 Rumsey and Harcourt 59 believe that many of these positive attributes buffer a patient from the distress of physical appearance alteration.
Previous studies have shown that skin cancer patients with the highest risk for anxiety are young, female, and have tumors on visible locations. 60, 61 The aforementioned PRO instruments may help identify patients with psychosocial distress in other demographic groups. For example, Caddick and colleagues 60 suggest that patients with lower FSCI scores be offered support services, such as self-help handouts, ready access to support organizations, and engaging friends or relatives for support, to cope with the effects of treatment, and recovery.
Referral to mental health professionals may be considered when the psychosocial burden is particularly great. Much of the literature that addresses coping strategies for altered facial appearance focuses on patients with significant facial disfigurement, a group of patients who shares limited similarities with patients with traditional skin cancer. Some psychological interventions have offered benefit for those with altered facial appearance. Cognitive behavioral therapy (CBT) has shown to improve body image, QOL, and self-esteem in patients with vitiligo and is often the first line of treatment for individuals suffering from significant facial disfigurement. 5, 62, 63 Patients in a disfigurement support unit experienced reduced anxiety, depression, and appearance-related distress with CBT. 64 Social interaction skill workshops for disfigured patients also reduced anxiety and social distress in disfigured patients. 65 However, a systematic review conducted on psychosocial interventions for patients with "visible differences" reported that the current strength of the evidence is limited. 66 Because of limited methodological quality and an inability to compare various interventions, the authors of the systematic review failed to produce favorable findings that other reviews reported. 67 Considering this, dermatological surgeons may want to consider screening for psychosocial distressimpairment in QOL, body image dissatisfaction, depression, and anxiety-in certain groups of patients with skin cancer (e.g., instances where significant facial deformity is anticipated or when a patient expressly admits to poor coping abilities). Additional studies for evaluation and management of psychosocial distress and scar concerns are warranted, but it has already been demonstrated that young females with NMSC and patients with tumors located on the lip are at risk for diminished QOL from their skin cancer. 68 Conversely, patients who are younger (<50 years old), have no prior NMSCs, and undergo less complex reconstructions experience significantly greater QOL improvement after skin cancer treatment. 68 If the surgeon and his or her staff have concerns about their ability to address the psychosocial status of a patient, referral to a known mental health professional (ideally someone with interest or expertise in health psychology, physical appearance, and body image) is recommended. 63, 69 
Conclusion
The growing number of skin cancer surgeries in the United States can leave scars that alter patient physical appearance and may dramatically decrease patient psychosocial functioning. Understanding the psychosocial impact of surgery for skin cancer can help physicians to improve the informed consent process as well as preoperative and postoperative counseling. Patient outcomes can be optimized by selecting the treatment modality that not only eradicates the skin cancer but also meets patient expectations regarding physical appearance.
